Provided by Tiger Trade Technology Pte. Ltd.

Cogent Biosciences, Inc.

33.90
-0.2800-0.82%
Volume:1.31M
Turnover:44.18M
Market Cap:5.88B
PE:-15.69
High:34.15
Open:33.50
Low:33.07
Close:34.18
52wk High:43.73
52wk Low:11.60
Shares:173.52M
Float Shares:166.83M
Volume Ratio:1.00
T/O Rate:0.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1600
EPS(LYR):-2.5504
ROE:-109.74%
ROA:-43.84%
PB:12.58
PE(LYR):-13.29

Loading ...

Cogent Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

Cogent Q1 net loss widens 35.28% to $97.4 million

Reuters
·
May 05

BRIEF-Cogent Biosciences Q1 Income From Operations USD -103.607 Million

Reuters
·
May 05

Cogent Biosciences Inc - Ended 1Q 2026 With $866.4 Mln in Cash, Sufficient to Fund Operations Into 2028

THOMSON REUTERS
·
May 05

Cogent Biosciences Q1 Net Income USD -97.352 Million

THOMSON REUTERS
·
May 05

A Look At Cogent Biosciences (COGT) Valuation After New KRAS And ErbB2 Data At AACR 2026

Simply Wall St.
·
Apr 27

Cogent Biosciences announces annual shareholder meeting

Reuters
·
Apr 24

Cogent says Phase 3 PEAK trial meets endpoint for bezuclastinib plus sunitinib in GIST

Reuters
·
Apr 21

Cogent Biosciences Announces Oral Presentation of Positive Phase 3 Peak Trial in Gastrointestinal Stromal Tumors (Gist) at the 2026 American Society of Clinical Oncology (Asco) Annual Meeting

THOMSON REUTERS
·
Apr 21

Lexicon COGT reports Q1 EPS $2.07, consensus $1.74

TIPRANKS
·
Apr 17

Cogent presents preclinical data on KRAS inhibitor CGT1263 at AACR 2026

Reuters
·
Apr 17

Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (Aacr) Annual Meeting 2026

THOMSON REUTERS
·
Apr 17

Southwest Airlines, Colliers International, and More Stocks See Action From Activist Investors -- Barrons.com

Dow Jones
·
Apr 11

Cogent Biosciences submits bezuclastinib new drug application to the FDA

TIPRANKS
·
Apr 01

Cogent submits FDA NDA for bezuclastinib in second-line GIST under RTOR program

Reuters
·
Apr 01

Fairmount Funds Management disposes of USD 243M Cogent Biosciences common shares

Reuters
·
Apr 01

LifeSci Capital Sticks to Their Buy Rating for Cogent Biosciences (COGT)

TIPRANKS
·
Mar 21

Cogent Biosciences Coverage Assumed by Jefferies at Buy

Dow Jones
·
Mar 17

BUZZ-U.S. STOCKS ON THE MOVE-Customers Bancorp, Forgent Power Solutions, Nvidia

Reuters
·
Mar 17

BUZZ-U.S. STOCKS ON THE MOVE-Dollar Tree, Micron, Customers Bancorp

Reuters
·
Mar 16